For not properly warning patients of the severe risk associated with taking their drug, manufacturers of Benicar are being sued.
Benicar is a medication known under the generic name olmesartan. This drug is classified as an angiotensin II receptor antagonist. It is designed to keep the blood vessels from narrowing, lowering blood pressure, and improving blood flow. Doctors write more than 11 million prescriptions for this drug each year.
Benicar can be taken on its own as a stand-alone blood pressure...Read More
A growing number of patients have filed a lawsuit against the drugs manufacturers. It is expected that several thousand complaints will be filed in courts nationwide over the next year. Benicar lawsuits claim that the manufacturers knew, or should have been aware, about the risk of intestinal problems that were a side effect.
Patients who are suffering from enteropathy...Read More
In July 2013, the FDA announced that Benicar would receive a label update, to warn against any and all side effects. The new drug information reflects that this medication may cause enteropathy, a...Read More